2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

By A. Tunkel, R. Hasbún, A. Bhimraj, K. Byers, S. Kaplan, W. Scheld, D. van de Beek, T. Bleck, H. Garton, J. Zunt. Clinical Infectious Diseases, 2017

906 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Microbiology, Surgery

View Paper: https://www.semanticscholar.org/paper/0e26250c954fc1fae8b3b5806e2831d3b200087d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Horcajada
2. M. Montero
3. L. Sorlí
4. S. Luque
5. S. Gómez-Zorrilla
6. N. Benito
7. S. Grau
8. A. Oliver

Citations in the corpus

• Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections (2019, background): “The current IDSA guidelines suggest an intrathecal dose of 10 mg of CMS or 5 mg of polymyxin B once daily (234).”
• Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition (2021, background): “Meropenem is not included and is acceptable to report on CSF isolates, when indicated, as this agent has been shown to be effective in treating meningitis (37).”